Fig. 4: Cumulative incidence of BCR::ABL1 KD mutations in adult CML patients according to the presence of ASXL1 mutation at the time of diagnosis.
The number of patients at risk is shown on the table below. ASXL1mut ASXL1 mutation at diagnosis, wt no mutation at diagnosis.
